Neurona Therapeutics’ Post

🌟 Join Us for the Cell Therapy for Neurological Disorders Summit (Dec 11th-13th , San Diego)🌟 I am excited to announce that I’ll be curating the audience for this upcoming summit in San Diego this December! For the first time at a cell therapy conference, the spotlight is on drug developers pioneering therapies for neurological disorders! 🧠 Join experts from Aspen Neuroscience, Kenai Therapeutics, Coya Therapeutics, Inteligex, and UCSD as they share their latest innovations in developing safe and effective cell therapies for the CNS, aiming to elevate the standard of care for millions affected by neurological disorders. This December, our community will dive into key topics, including: ✔ Preclinical and clinical findings across various indications, such as ALS, MS, Alzheimer’s, and Parkinson’s. ✔ The pressing need for improved preclinical models to streamline the transition to clinical trials. ✔ Patient challenges, including immunosuppression, placebo effects, and the delivery of these therapies to the brain and nervous system. Full session details are available here: https://ter.li/h3ogz8 Feel free to connect with me on LinkedIn or email me at amir.abdirahman@hansonwade.com with any queries regarding this years event. Register Here : https://lnkd.in/eY9_JEnN #Celltherapy #CellTherapyNeuro #CellTherapyForNeurologicalDisorders #ALS #MS #MultipleSclerosis #Parkinsons #Alzheimers #Stroke #Epilepsy

Will you be attending the Cell Therapy for Neurological Disorders Summit this December? Boasting clinical presentations from experts including Kenai Therapeutics, Aspen Neuroscience, Inc., Neurona Therapeutics, and UC San Diego, this summit is your chance to drive innovation in neurological care.   Find out more in our 2024 agenda: https://ter.li/vi7043   🚀 Discuss the scope and landscape of cell therapy for neurological disease with Jim Musick and Xiaokui Zhang, PhD 🚀 Explore the unique challenges in manufacturing scale-up with Brian Culley 🚀 Evaluate preclinical models to streamline your pipeline with Mark Tuszynski, Jeanne Loring and Igor Lavrov, MD, PhD   Intrigued? Don't miss your chance to save up to $760 on your pass - https://ter.li/ky727w #celltherapy #neurologicaldisorders #CTxNeuro

Sensitivity of the Preclinical Alzheimer’s Cognitive Composite (PACC), PACC5, and Repeatable Battery for Neuropsychological Status (RBANS) to Amyloid Status in Preclinical Alzheimer’s Disease..... Papp, K.V., et al. https://lnkd.in/e4AMKteK #Alzheimerscognitive #Amyloid #Neuropsychological

💥 Newly Cited Article 🎯 "Stem cell therapy in neurological disorders: promises and concerns" by Prof. Said Hachimi-Idrissi 🔎 Full text: https://lnkd.in/gVFHvW2e 📑 PDF: https://lnkd.in/gU9XqjVu 📚 This article belongs to the special issue "Therapeutic Targets for Neuroprotection in Ischemic Stroke". View more articles at https://lnkd.in/gndweaEu #Neuralstemcells #embryonicstemcells #inducedpluripotentstemcells #adultmesenchymalstem #neurologicaldisorders

💥 Newly Cited Article 🎯 "Stem cell therapy in neurological disorders: promises and concerns" by Prof. Said Hachimi-Idrissi 🔎 Full text: https://lnkd.in/gJVK23g3 📑 PDF: https://lnkd.in/gvZGpkve 📚 This article belongs to the special issue "Therapeutic Targets for Neuroprotection in Ischemic Stroke". View more articles at https://lnkd.in/gHeztvt7 #Neuralstemcells #embryonicstemcells #inducedpluripotentstemcells #adultmesenchymalstem #neurologicaldisorders

Sudden Unexpected Death in Epilepsy (SUDEP) remains a critical concern in epilepsy management, with the underlying mechanisms still not fully understood. Our latest blog explores a recent study by Iyer, S., et al (2024) that investigates how altered ventilatory responses to hypercapnia-hypoxia (HH) challenges in a preclinical SUDEP model implicate orexin neurons: https://hubs.ly/Q02Gy87z0 #SUDEP #Orexins #Plethysmography #NeuralControlOfBreathing

Learn the key considerations for utilizing #RANO 2.0 criteria when assessing #Glioblastoma treatments in #ClinicalTrials. Read the blog by Calyx's Elif Sikoglu https://lnkd.in/gp8G-rv6 #MedicalImaging #NeuroOncology #ChooseCalyx

Learn the key considerations for utilizing #RANO 2.0 criteria when assessing #Glioblastoma treatments in #ClinicalTrials. Read the blog by Calyx's Elif Sikoglu https://lnkd.in/dq6H6uCv #MedicalImaging #NeuroOncology #ChooseCalyx

Learn the key considerations for utilizing #RANO 2.0 criteria when assessing #Glioblastoma treatments in #ClinicalTrials. Read the blog by Calyx's Elif Sikoglu https://lnkd.in/g5VTKzFz #MedicalImaging #NeuroOncology #ChooseCalyx

🔔 We are glad to share the following publication in the Journal of Clinical Medicine (JCM) MDPI: 📝 Development of CAR T Cell Therapy in Children—A Comprehensive Overview ✨10.3390/jcm11082158